• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6例妊娠滋养细胞肿瘤化疗后并发心脏毒性的临床分析

[Clinical analysis of 6 cases of gestational trophoblastic neoplasms complicated by cardiotoxicity after chemotherapies].

作者信息

Wu Y, Qian H

机构信息

People's Hospital, Beijing Medical University.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 1995 Jun;30(6):366-8.

PMID:7555374
Abstract

Gestational trophoblastic neoplasm treated by large dosage of 5-fluorouracil and actinomycin could cause cardiotoxicity. In 6 cases of gestational trophoblastic neoplasms admitted to our hospital from March to December 1993, cardiotoxicity was found to have occurred after chemotherapies in 10/21 courses. There were 2 cases with heart failures, 4 cases with palpitation and 4 cases with feelings of oppression and (or) chest pains. In 7 cases the electrocardiogram (EKG) findings were abnormal (70.0%) and in 5 cases there were increased sera glutamic oxalacetic transaminase enzyme (AST). 90.0% of these complications were brought under control after decreasing the dosages and changing the methods of administration. If the proper managements were not given on time, patient may even expire. So attention should be paid to this complication. It is suggested that attention should be paid to patients' subjective symptoms, and proper surveillance by EKG and serum AST determinations should be conducted to minimize deaths due to chemotherapeutic complications.

摘要

大剂量5-氟尿嘧啶和放线菌素治疗妊娠滋养细胞肿瘤可引起心脏毒性。在1993年3月至12月我院收治的6例妊娠滋养细胞肿瘤患者中,21个疗程化疗后有10个疗程出现心脏毒性。有2例发生心力衰竭,4例有心悸,4例有压迫感和(或)胸痛。7例心电图(EKG)检查结果异常(70.0%),5例血清谷氨酸草酰乙酸转氨酶(AST)升高。降低剂量并改变给药方法后,90.0%的这些并发症得到了控制。若不及时给予恰当处理,患者甚至可能死亡。因此应重视这一并发症。建议关注患者的主观症状,并通过心电图和血清AST测定进行适当监测,以尽量减少化疗并发症导致的死亡。

相似文献

1
[Clinical analysis of 6 cases of gestational trophoblastic neoplasms complicated by cardiotoxicity after chemotherapies].6例妊娠滋养细胞肿瘤化疗后并发心脏毒性的临床分析
Zhonghua Fu Chan Ke Za Zhi. 1995 Jun;30(6):366-8.
2
Mono and polichemotherapy in the treatment of metastatic and invasive gestational trophoblastic disease: analysis of 50 cases.单药与多药化疗治疗转移性和侵袭性妊娠滋养细胞疾病:50例分析
Rev Paul Med. 1993 Nov-Dec;111(6):433-8.
3
Placental site trophoblastic tumor: an overview.胎盘部位滋养细胞肿瘤:概述
J Reprod Med. 2004 Aug;49(8):585-8.
4
[Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].依托泊苷、甲氨蝶呤、更生霉素/依托泊苷、顺铂化疗用于化疗难治性妊娠滋养细胞肿瘤
Zhonghua Fu Chan Ke Za Zhi. 2005 Feb;40(2):79-82.
5
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.持续性妊娠滋养细胞疾病:甲氨蝶呤、依托泊苷和放线菌素D(MEA)作为高危疾病一线化疗方案以及依托泊苷和放线菌素D(EA)作为低危疾病二线治疗方案的疗效
Br J Cancer. 2000 May;82(9):1547-52. doi: 10.1054/bjoc.2000.1176.
6
Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.依托泊苷、甲氨蝶呤和放线菌素D治疗后甲氨蝶呤单药治疗高危妊娠滋养细胞肿瘤:一例报告
Am J Obstet Gynecol. 2008 Nov;199(5):e6-8. doi: 10.1016/j.ajog.2008.07.045.
7
Liver metastases of gestational trophoblastic tumor.妊娠滋养细胞肿瘤肝转移
Gynecol Oncol. 1993 Jan;48(1):110-3. doi: 10.1006/gyno.1993.1017.
8
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.采用依托泊苷-甲氨蝶呤-放线菌素D/环磷酰胺-长春新碱交替每周化疗治疗高危妊娠滋养细胞疾病。
Obstet Gynecol. 1994 Jan;83(1):113-7.
9
Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.甲氨蝶呤、依托泊苷和放线菌素D联合化疗用于高危妊娠滋养细胞肿瘤
Gynecol Oncol. 2000 Jul;78(1):28-31. doi: 10.1006/gyno.2000.5813.
10
Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.接受依托泊苷、甲氨蝶呤、放线菌素、环磷酰胺和长春新碱(EMA-CO)化疗的滋养细胞肿瘤患者的血浆甲氨蝶呤水平。
Gynecol Oncol. 1993 Sep;50(3):300-4. doi: 10.1006/gyno.1993.1215.